vs
ExlService Holdings, Inc.（EXLS）とMERIT MEDICAL SYSTEMS INC（MMSI）の財務データ比較。上の社名をクリックして会社を切り替えられます
ExlService Holdings, Inc.の直近四半期売上が大きい（$542.6M vs $393.9M、MERIT MEDICAL SYSTEMS INCの約1.4倍）。ExlService Holdings, Inc.の純利益率が高く（11.1% vs 9.6%、差は1.5%）。ExlService Holdings, Inc.の前年同期比売上増加率が高い（12.7% vs 10.9%）。ExlService Holdings, Inc.の直近四半期フリーキャッシュフローが多い（$106.5M vs $74.0M）。過去8四半期でExlService Holdings, Inc.の売上複合成長率が高い（11.5% vs 10.3%）
ExlService Holdings Inc.は保険、ヘルスケア、銀行・金融サービス、メディア、小売などの業界を対象に分析・デジタルソリューションを提供するグローバル企業で、本社はニューヨークに所在し、米国、欧州、アジア、中南米、オーストラリア、南アフリカなど世界各地に5万4000人以上の専門スタッフを擁しています。
メリットメディカルシステムズ社はグローバルな医療機器メーカーで、心臓病学、放射線学、腫瘍学、内視鏡検査、救命救護の各分野で使用される介入・診断用製品を開発・製造・販売しています。世界中の病院や医療機関に低侵襲のソリューションを提供し、患者の予後改善と診療効率の向上を支援しています。
EXLS vs MMSI — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $542.6M | $393.9M |
| 純利益 | $60.2M | $38.0M |
| 粗利率 | 38.6% | 49.6% |
| 営業利益率 | 14.4% | 13.8% |
| 純利益率 | 11.1% | 9.6% |
| 売上前年比 | 12.7% | 10.9% |
| 純利益前年比 | 18.9% | 36.0% |
| EPS（希薄化後） | $0.38 | $0.64 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $542.6M | $393.9M | ||
| Q3 25 | $529.6M | $384.2M | ||
| Q2 25 | $514.5M | $382.5M | ||
| Q1 25 | $501.0M | $355.4M | ||
| Q4 24 | $481.4M | $355.2M | ||
| Q3 24 | $472.1M | $339.8M | ||
| Q2 24 | $448.4M | $338.0M | ||
| Q1 24 | $436.5M | $323.5M |
| Q4 25 | $60.2M | $38.0M | ||
| Q3 25 | $58.2M | $27.8M | ||
| Q2 25 | $66.1M | $32.6M | ||
| Q1 25 | $66.6M | $30.1M | ||
| Q4 24 | $50.7M | $27.9M | ||
| Q3 24 | $53.0M | $28.4M | ||
| Q2 24 | $45.8M | $35.7M | ||
| Q1 24 | $48.8M | $28.2M |
| Q4 25 | 38.6% | 49.6% | ||
| Q3 25 | 38.5% | 48.5% | ||
| Q2 25 | 37.7% | 48.2% | ||
| Q1 25 | 38.6% | 48.4% | ||
| Q4 24 | 38.1% | 48.7% | ||
| Q3 24 | 37.8% | 46.4% | ||
| Q2 24 | 37.1% | 47.7% | ||
| Q1 24 | 37.4% | 46.9% |
| Q4 25 | 14.4% | 13.8% | ||
| Q3 25 | 14.4% | 11.1% | ||
| Q2 25 | 15.8% | 12.3% | ||
| Q1 25 | 15.7% | 11.5% | ||
| Q4 24 | 14.8% | 10.3% | ||
| Q3 24 | 14.7% | 11.0% | ||
| Q2 24 | 13.7% | 13.6% | ||
| Q1 24 | 14.1% | 11.1% |
| Q4 25 | 11.1% | 9.6% | ||
| Q3 25 | 11.0% | 7.2% | ||
| Q2 25 | 12.8% | 8.5% | ||
| Q1 25 | 13.3% | 8.5% | ||
| Q4 24 | 10.5% | 7.9% | ||
| Q3 24 | 11.2% | 8.4% | ||
| Q2 24 | 10.2% | 10.6% | ||
| Q1 24 | 11.2% | 8.7% |
| Q4 25 | $0.38 | $0.64 | ||
| Q3 25 | $0.36 | $0.46 | ||
| Q2 25 | $0.40 | $0.54 | ||
| Q1 25 | $0.40 | $0.49 | ||
| Q4 24 | $0.31 | $0.46 | ||
| Q3 24 | $0.33 | $0.48 | ||
| Q2 24 | $0.28 | $0.61 | ||
| Q1 24 | $0.29 | $0.48 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $328.4M | $446.4M |
| 総負債低いほど良い | $298.6M | $734.0M |
| 株主資本純資産 | $912.7M | $1.6B |
| 総資産 | $1.7B | $2.7B |
| 負債/資本比率低いほどレバレッジが低い | 0.33× | 0.46× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $328.4M | $446.4M | ||
| Q3 25 | $390.1M | $392.5M | ||
| Q2 25 | $353.3M | $341.8M | ||
| Q1 25 | $331.4M | $395.5M | ||
| Q4 24 | $340.6M | $376.7M | ||
| Q3 24 | $325.8M | $523.1M | ||
| Q2 24 | $276.1M | $636.7M | ||
| Q1 24 | $246.2M | $581.9M |
| Q4 25 | $298.6M | $734.0M | ||
| Q3 25 | $354.8M | $732.9M | ||
| Q2 25 | $260.0M | $731.8M | ||
| Q1 25 | $307.3M | $730.7M | ||
| Q4 24 | $288.5M | $729.6M | ||
| Q3 24 | $344.7M | $750.5M | ||
| Q2 24 | — | $801.3M | ||
| Q1 24 | — | $800.1M |
| Q4 25 | $912.7M | $1.6B | ||
| Q3 25 | $952.4M | $1.5B | ||
| Q2 25 | $1.1B | $1.5B | ||
| Q1 25 | $1.0B | $1.4B | ||
| Q4 24 | $929.9M | $1.4B | ||
| Q3 24 | $907.6M | $1.3B | ||
| Q2 24 | $852.6M | $1.3B | ||
| Q1 24 | $803.3M | $1.2B |
| Q4 25 | $1.7B | $2.7B | ||
| Q3 25 | $1.7B | $2.6B | ||
| Q2 25 | $1.7B | $2.6B | ||
| Q1 25 | $1.7B | $2.5B | ||
| Q4 24 | $1.6B | $2.4B | ||
| Q3 24 | $1.6B | $2.4B | ||
| Q2 24 | $1.5B | $2.4B | ||
| Q1 24 | $1.4B | $2.3B |
| Q4 25 | 0.33× | 0.46× | ||
| Q3 25 | 0.37× | 0.48× | ||
| Q2 25 | 0.25× | 0.49× | ||
| Q1 25 | 0.30× | 0.51× | ||
| Q4 24 | 0.31× | 0.53× | ||
| Q3 24 | 0.38× | 0.57× | ||
| Q2 24 | — | 0.62× | ||
| Q1 24 | — | 0.65× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $117.4M | $98.5M |
| フリーキャッシュフロー営業CF - 設備投資 | $106.5M | $74.0M |
| FCFマージンFCF / 売上 | 19.6% | 18.8% |
| 設備投資強度設備投資 / 売上 | 2.0% | 6.2% |
| キャッシュ転換率営業CF / 純利益 | 1.95× | 2.59× |
| 直近12ヶ月FCF直近4四半期 | $298.1M | $215.7M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $117.4M | $98.5M | ||
| Q3 25 | $120.7M | $75.0M | ||
| Q2 25 | $109.4M | $83.3M | ||
| Q1 25 | $3.2M | $40.6M | ||
| Q4 24 | $105.3M | $68.7M | ||
| Q3 24 | $110.1M | $47.3M | ||
| Q2 24 | $74.9M | $68.5M | ||
| Q1 24 | $-21.9M | $36.2M |
| Q4 25 | $106.5M | $74.0M | ||
| Q3 25 | $106.4M | $52.5M | ||
| Q2 25 | $95.0M | $69.6M | ||
| Q1 25 | $-9.7M | $19.5M | ||
| Q4 24 | $95.3M | $65.3M | ||
| Q3 24 | $97.3M | $38.0M | ||
| Q2 24 | $62.8M | $57.9M | ||
| Q1 24 | $-33.1M | $24.5M |
| Q4 25 | 19.6% | 18.8% | ||
| Q3 25 | 20.1% | 13.7% | ||
| Q2 25 | 18.5% | 18.2% | ||
| Q1 25 | -1.9% | 5.5% | ||
| Q4 24 | 19.8% | 18.4% | ||
| Q3 24 | 20.6% | 11.2% | ||
| Q2 24 | 14.0% | 17.1% | ||
| Q1 24 | -7.6% | 7.6% |
| Q4 25 | 2.0% | 6.2% | ||
| Q3 25 | 2.7% | 5.8% | ||
| Q2 25 | 2.8% | 3.6% | ||
| Q1 25 | 2.6% | 5.9% | ||
| Q4 24 | 2.1% | 1.0% | ||
| Q3 24 | 2.7% | 2.8% | ||
| Q2 24 | 2.7% | 3.1% | ||
| Q1 24 | 2.6% | 3.6% |
| Q4 25 | 1.95× | 2.59× | ||
| Q3 25 | 2.08× | 2.70× | ||
| Q2 25 | 1.66× | 2.56× | ||
| Q1 25 | 0.05× | 1.35× | ||
| Q4 24 | 2.08× | 2.46× | ||
| Q3 24 | 2.08× | 1.66× | ||
| Q2 24 | 1.63× | 1.92× | ||
| Q1 24 | -0.45× | 1.28× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EXLS
| Insurance | $185.8M | 34% |
| Healthcare And Life Sciences | $142.2M | 26% |
| Banking Capital Markets And Diversified Industries | $122.6M | 23% |
| International Growth Markets | $92.0M | 17% |
MMSI
| Other | $154.6M | 39% |
| Peripheral Intervention | $93.2M | 24% |
| Cardiac Intervention | $50.2M | 13% |
| OEM | $42.6M | 11% |
| Custom Procedural Solutions | $33.1M | 8% |
| Endoscopy Segment | $20.1M | 5% |
